Skip to main content
GIPResearch.com · Patent and Technology Research

Novartis

This directory groups existing GIPResearch.com articles associated with Novartis. Entries represent previously published material, not a current patent-register or regulatory determination. Novartis AG Receives Patent in India for Glycoside.

Save or follow this source
These actions open third-party AI services. Saving, citation, and future recall are not guaranteed.
Conceptual GIPResearch illustration for Novartis
Research and original publication material

Novartis — research background

This directory groups existing GIPResearch.com articles associated with Novartis. Entries represent previously published material, not a current patent-register or regulatory determination.

Novartis AG Receives Patent in India for Glycoside Derivatives to Treat Diabetes

NOVARTIS AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. The disease focus areas of Novartis.

Novartis AG Receives a Patent for Acrylic Ophthalmic Device

NOVARTIS AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. The disease focus areas of Novartis.

NOVARTIS AG Received a Patent for Purification Method

NOVARTIS AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. The disease focus areas of Novartis.

NOVARTIS AG Received a Patent for Various Inhibitors

NOVARTIS AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. The disease focus areas of Novartis.

NOVARTIS AG Received a Patent for Inhibiting the Activity of BCR-ABL1 and Mutants

NOVARTIS AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. The disease focus areas of Novartis.

Novartis AG Received a Patent for MANUFACTURING 5-(2,6-DI-4-MORPHOLINYL-4-PYRIMIDINYL)-4-TRIFLUORO-METHYLPYRIDIN-2-AMINE

Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company uses innovative science and digital.

Patent granted in India to NOVARTIS AG

As per the patent office journal dated 27/07/2021 , patent number 372099, has been granted to NOVARTIS AG titled COMPOSITIONS AND.

Discuss a research question related to Novartis

Describe your objective and the evidence you need. The suitability and scope of any research engagement will be confirmed individually.

Discuss a research question

Discuss a research question related to Novartis

Describe your objective and the evidence you need. The suitability and scope of any research engagement will be confirmed individually.

Discuss a research question

Source and context: Original GIPResearch.com publication. Existing text is retained for historical continuity. Verify time-sensitive matters using official records.

None

Featured Work & Insights